16-1229340-T-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_024164.6(TPSB2):​c.350A>T​(p.Gln117Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000079 ( 1 hom., cov: 5)
Exomes 𝑓: 0.000036 ( 4 hom. )
Failed GnomAD Quality Control

Consequence

TPSB2
NM_024164.6 missense

Scores

1
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.81
Variant links:
Genes affected
TPSB2 (HGNC:14120): (tryptase beta 2) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III. Beta tryptases appear to be the main isoenzymes expressed in mast cells, whereas in basophils, alpha-tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21444035).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TPSB2NM_024164.6 linkuse as main transcriptc.350A>T p.Gln117Leu missense_variant 4/6 ENST00000606293.5 NP_077078.5 P20231A0A140VJT7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TPSB2ENST00000606293.5 linkuse as main transcriptc.350A>T p.Gln117Leu missense_variant 4/61 NM_024164.6 ENSP00000482743.1 P20231
TPSB2ENST00000612142.1 linkuse as main transcriptc.371A>T p.Gln124Leu missense_variant 3/51 ENSP00000478695.1 A0A087WUI4
TPSB2ENST00000611196.4 linkuse as main transcriptn.350A>T non_coding_transcript_exon_variant 4/81 ENSP00000484461.1 A0A087X1U0

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
2
AN:
25250
Hom.:
1
Cov.:
5
FAILED QC
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000130
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000604
AC:
4
AN:
66190
Hom.:
1
AF XY:
0.0000869
AC XY:
3
AN XY:
34504
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000360
AC:
21
AN:
583122
Hom.:
4
Cov.:
7
AF XY:
0.0000269
AC XY:
8
AN XY:
297176
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000484
Gnomad4 OTH exome
AF:
0.0000350
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000792
AC:
2
AN:
25250
Hom.:
1
Cov.:
5
AF XY:
0.000183
AC XY:
2
AN XY:
10904
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000130
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000743
Hom.:
0
ExAC
AF:
0.0000552
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 10, 2024The c.350A>T (p.Q117L) alteration is located in exon 4 (coding exon 3) of the TPSB2 gene. This alteration results from a A to T substitution at nucleotide position 350, causing the glutamine (Q) at amino acid position 117 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
5.2
DANN
Benign
0.77
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.065
N
LIST_S2
Benign
0.032
T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.21
T;T
MetaSVM
Benign
-0.53
T
PrimateAI
Benign
0.29
T
Sift4G
Benign
0.27
T;T
Vest4
0.20
MutPred
0.44
Loss of catalytic residue at Q117 (P = 0.061);.;
MVP
0.11
ClinPred
0.61
D
GERP RS
0.72
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs773678304; hg19: chr16-1279341; API